Document is current
Any future updates will be listed below
-
Authors
Bode, Merle https://orcid.org/0000-0003-4870-7841
Kalbe, Elke https://orcid.org/0000-0001-8603-2545
Liepelt-Scarfone, Inga https://orcid.org/0000-0002-0875-892X
-
Funding
Funding for this research was provided by:
German Ministry of Education and Research
General Joint Committee
Deutsche Gesellschaft für Parkinson und Bewegungsstörungen
STADAPHARM GmbH
AbbVie GmbH Germany
Bayer
Desitin Arzneimittel
Deutsche Gesellschaft für Neurologie
Universitätsklinikum Tübingen
- License Information
-
More Information
Article History
Received: 12 April 2024
Accepted: 8 June 2024
First Online: 8 July 2024
Declarations
:
: M. Bode reports no financial interests. E. Kalbe has received grants from the German Ministry of Education and Research, General Joint Committee, Germany, the German Parkinson Society, and STADAPHARM GmbH; honoraria from AbbVie GmbH Germany; memodio GmbH Germany; license fees from Prolog GmbH, Germany.I. Liepelt-Scarfone reports funding from Bayer AG and travel grants from Desitin and the Deutsche Gesellschaft für Neurologie outside the submitted work.
